Permira agrees to sell I-MED to London-listed conglomerate for $3.4b

Australian Financial Review online

www.afr.com

The acquisition includes I-MED’s stake in Harrison.AI  and is an all-cash offer, with nothing deferred and no earn-out. Jardine’s objective is to be a long-term owner and focus on growth, the sources said.